BAJAJHCAREPharmaceuticals
Bajaj Healthcare Ltd — Profit & Loss Statement
₹290.10
-4.21%
Bajaj Healthcare Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | -6.24 Cr | 0.15 Cr | -0.02 Cr | — |
| Tax Rate For Calcs | 0.07 | 0.14 | 0.19 | 0.20 | — |
| Normalized EBITDA | 101.83 Cr | 88.78 Cr | 121.13 Cr | 118.44 Cr | — |
| Total Unusual Items | 0.00 | -44.33 Cr | 0.81 Cr | -0.11 Cr | — |
| Total Unusual Items Excluding Goodwill | 0.00 | -44.33 Cr | 0.81 Cr | -0.11 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 42.93 Cr | -14.33 Cr | 63.53 Cr | 71.39 Cr | — |
| Reconciled Depreciation | 27.92 Cr | 31.45 Cr | 27.36 Cr | 17.64 Cr | — |
| Reconciled Cost Of Revenue | 286.45 Cr | 254.77 Cr | 386.88 Cr | 496.05 Cr | — |
| EBITDA | 101.83 Cr | 44.45 Cr | 121.94 Cr | 118.32 Cr | — |
| EBIT | 73.91 Cr | 13.00 Cr | 94.58 Cr | 100.69 Cr | — |
| Net Interest Income | -27.90 Cr | -29.68 Cr | -17.25 Cr | -12.61 Cr | — |
| Interest Expense | 27.90 Cr | 29.68 Cr | 16.40 Cr | 11.00 Cr | — |
| Normalized Income | 42.93 Cr | 23.76 Cr | 62.87 Cr | 71.48 Cr | — |
| Net Income From Continuing And Discontinued Operation | 39.50 Cr | -83.79 Cr | 43.02 Cr | 71.39 Cr | — |
| Total Expenses | 488.09 Cr | 424.77 Cr | 551.49 Cr | 575.78 Cr | — |
| Diluted Average Shares | 3.01 Cr | 2.76 Cr | 2.76 Cr | 2.76 Cr | — |
| Basic Average Shares | 2.97 Cr | 2.76 Cr | 2.76 Cr | 2.76 Cr | — |
| Diluted EPS | 13.12 | -30.36 | 15.59 | 25.87 | — |
| Basic EPS | 13.29 | -30.36 | 15.59 | 25.87 | — |
| Diluted NI Availto Com Stockholders | 39.50 Cr | -83.79 Cr | 43.02 Cr | 71.39 Cr | — |
| Net Income Common Stockholders | 39.50 Cr | -83.79 Cr | 43.02 Cr | 71.39 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 39.50 Cr | -83.79 Cr | 43.02 Cr | 71.39 Cr | — |
| Net Income Including Noncontrolling Interests | 39.50 Cr | -83.79 Cr | 43.02 Cr | 71.39 Cr | — |
| Net Income Discontinuous Operations | -3.43 Cr | -69.47 Cr | -20.51 Cr | — | — |
| Net Income Continuous Operations | 42.93 Cr | -14.33 Cr | 63.53 Cr | 71.39 Cr | — |
| Tax Provision | 3.08 Cr | -2.35 Cr | 14.65 Cr | 18.30 Cr | — |
| Pretax Income | 46.01 Cr | -16.68 Cr | 78.18 Cr | 89.68 Cr | — |
| Other Non Operating Income Expenses | 19.40 Cr | 8.69 Cr | 0.31 Cr | 0.25 Cr | — |
| Special Income Charges | 0.00 | -44.33 Cr | 0.81 Cr | -0.11 Cr | — |
| Net Non Operating Interest Income Expense | -27.90 Cr | -29.68 Cr | -17.25 Cr | -12.61 Cr | — |
| Interest Expense Non Operating | 27.90 Cr | 29.68 Cr | 16.40 Cr | 11.00 Cr | — |
| Operating Income | 54.51 Cr | 48.65 Cr | 94.31 Cr | 104.11 Cr | — |
| Operating Expense | 201.65 Cr | 170.00 Cr | 164.61 Cr | 79.73 Cr | — |
| Other Operating Expenses | 116.67 Cr | 98.53 Cr | 61.59 Cr | 13.69 Cr | — |
| Depreciation And Amortization In Income Statement | 27.92 Cr | 27.62 Cr | 17.21 Cr | 17.64 Cr | — |
| Depreciation Income Statement | 27.92 Cr | 27.62 Cr | 17.09 Cr | 17.64 Cr | — |
| Gross Profit | 256.16 Cr | 218.65 Cr | 258.91 Cr | 183.84 Cr | — |
| Cost Of Revenue | 286.45 Cr | 254.77 Cr | 386.88 Cr | 496.05 Cr | — |
| Total Revenue | 542.60 Cr | 473.42 Cr | 645.80 Cr | 679.89 Cr | — |
| Operating Revenue | 542.60 Cr | 473.42 Cr | 645.80 Cr | 679.89 Cr | — |
| Interest Income | — | 0.33 Cr | 0.43 Cr | 0.17 Cr | 0.17 Cr |
| Rent Expense Supplemental | — | 1.18 Cr | 1.46 Cr | 1.23 Cr | 1.25 Cr |
| Other Special Charges | — | 37.97 Cr | -0.82 Cr | 0.08 Cr | -0.01 Cr |
| Write Off | — | 0.00 | 0.01 Cr | 0.03 Cr | 0.01 Cr |
| Total Other Finance Cost | — | 0.69 Cr | 1.28 Cr | 1.78 Cr | — |
| Interest Income Non Operating | — | 0.33 Cr | 0.43 Cr | 0.17 Cr | 0.17 Cr |
| Amortization | — | 0.21 Cr | 0.12 Cr | — | — |
| Selling General And Administration | — | 15.41 Cr | 21.40 Cr | 7.07 Cr | 6.14 Cr |
| Selling And Marketing Expense | — | 9.67 Cr | 15.97 Cr | 0.09 Cr | 0.57 Cr |
| General And Administrative Expense | — | 5.74 Cr | 5.43 Cr | 6.98 Cr | 5.57 Cr |
| Rent And Landing Fees | — | 1.18 Cr | 1.46 Cr | 1.23 Cr | 1.25 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Bajaj Healthcare Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.